Nervgen Pharma (NGEN) Assets Average (2026)

Nervgen Pharma (NGEN) has reported Assets Average for 1 consecutive years, with $40.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average changed N/A year-over-year to $40.2 million in Q2 2026; TTM through Jun 2026 was $40.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $15.4 million, changed N/A from the prior year.
• Assets Average was $40.2 million for Q2 2026 at Nervgen Pharma, up from $15.9 million in the prior quarter.
• Over five years, Assets Average peaked at $40.2 million in Q2 2026 and troughed at $15.9 million in Q1 2026.